Guido Marcucci Selected Research

Guido Marcucci Research Topics

Disease

164	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2024 - 09/2003
94	Neoplasms (Cancer) 05/2024 - 05/2005
82	Leukemia 02/2024 - 02/2002
28	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2023 - 07/2007
16	Graft vs Host Disease (Graft-Versus-Host Disease) 11/2023 - 07/2008
13	Hematologic Neoplasms (Hematological Malignancy) 04/2024 - 01/2006
13	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 02/2024 - 04/2003
12	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022 - 05/2005
12	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2014 - 07/2003
11	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 04/2003
9	Philadelphia Chromosome 02/2017 - 04/2003
8	Lymphoma (Lymphomas) 03/2024 - 05/2006
8	Blast Crisis (Blast Phase) 01/2022 - 11/2005
7	Breast Neoplasms (Breast Cancer) 03/2024 - 08/2009
7	B-Cell Lymphoma (Lymphoma, B Cell) 03/2024 - 05/2006
7	Multiple Myeloma 01/2021 - 06/2008
6	Infections 01/2023 - 09/2004
6	Carcinogenesis 01/2020 - 10/2007
5	Disease Progression 11/2023 - 10/2013
4	Cytokine Release Syndrome 01/2023 - 01/2020
4	Residual Neoplasm 02/2022 - 12/2016
4	Primary Myelofibrosis (Myelosclerosis) 01/2022 - 01/2019
4	Inflammation (Inflammations) 01/2020 - 09/2007
4	Myeloid Leukemia (Leukemia, Myelocytic) 01/2019 - 04/2005
3	COVID-19 01/2023 - 01/2023
3	Colonic Neoplasms (Colon Cancer) 10/2020 - 11/2011
3	Large Granular Lymphocytic Leukemia 11/2012 - 05/2009
3	Carcinoma (Carcinomatosis) 01/2010 - 04/2005
2	Prostatic Neoplasms (Prostate Cancer) 05/2024 - 11/2011

Drug/Important Bio-Agent (IBA)

38	MicroRNAs (MicroRNA)IBA 01/2022 - 10/2007
30	Proteins (Proteins, Gene)FDA Link 11/2023 - 07/2003
24	venetoclaxIBA 05/2024 - 03/2014
19	Cytarabine (Cytosar-U)FDA LinkGeneric 11/2023 - 01/2003
17	Decitabine FDA Link 01/2023 - 01/2006
12	Messenger RNA (mRNA)IBA 01/2023 - 01/2009
11	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023 - 05/2006
11	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2005
10	Tyrosine Kinase InhibitorsIBA 02/2024 - 10/2013
10	Core Binding Factors (Core-Binding Factor)IBA 01/2021 - 09/2003
10	RNA (Ribonucleic Acid)IBA 01/2021 - 06/2009
10	Phosphotransferases (Kinase)IBA 01/2019 - 11/2005
10	oblimersen (G3139)IBA 01/2010 - 01/2003
8	Histone Deacetylase InhibitorsIBA 11/2023 - 01/2004
8	fludarabineIBA 11/2023 - 01/2003
8	Histones (Histone)IBA 11/2019 - 07/2003
8	MethyltransferasesIBA 01/2018 - 02/2005
7	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2022 - 06/2008
7	OligonucleotidesIBA 01/2020 - 06/2009
7	Bortezomib (Velcade)FDA Link 01/2016 - 05/2006
7	Antisense OligonucleotidesIBA 06/2015 - 01/2003
7	Histone Deacetylases (Histone Deacetylase)IBA 12/2012 - 07/2003
7	DepsipeptidesIBA 12/2006 - 06/2003
6	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2005
6	Tacrolimus (Prograf)FDA LinkGeneric 11/2023 - 01/2016
6	Sirolimus (Rapamycin)FDA Link 11/2023 - 01/2016
6	Lenalidomide (CC 5013)FDA Link 12/2020 - 12/2008
6	mouse MIRN29 microRNAIBA 01/2019 - 06/2009
6	Transcription Factors (Transcription Factor)IBA 12/2016 - 05/2012
6	GTI2040IBA 06/2015 - 06/2006
5	midostaurinIBA 04/2024 - 01/2016
5	N-methyladenosineIBA 01/2023 - 11/2018
5	6-methyladenineIBA 12/2022 - 01/2018
5	blinatumomabIBA 02/2022 - 09/2017
5	CytokinesIBA 10/2021 - 02/2002
5	Protein Isoforms (Isoforms)IBA 01/2019 - 01/2013
4	fms-Like Tyrosine Kinase 3IBA 01/2024 - 01/2017
4	Interleukin-15 (Interleukin 15)IBA 01/2023 - 04/2011
4	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 01/2018
4	EnzymesIBA 12/2020 - 10/2007
4	Etoposide (VP 16)FDA LinkGeneric 01/2020 - 12/2006
4	Azacitidine (5 Azacytidine)FDA Link 01/2019 - 05/2005
4	romidepsin (FK228)FDA Link 07/2005 - 06/2003
3	Monoclonal AntibodiesIBA 01/2023 - 07/2008
3	Oncogene Proteins (Oncogene Protein)IBA 01/2023 - 03/2006
3	triphosphoric acid (triphosphate)IBA 01/2022 - 06/2009
3	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2022 - 03/2013
3	daratumumabIBA 01/2021 - 01/2018
3	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2021 - 01/2013
3	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2016 - 05/2008
3	NucleophosminIBA 04/2014 - 05/2008
3	Imatinib Mesylate (Gleevec)FDA Link 01/2014 - 04/2003
3	Transferrin (beta 2 Transferrin)IBA 05/2013 - 06/2009
3	Liposomes (Liposome)IBA 01/2013 - 01/2010
3	Folic Acid (Vitamin M)FDA LinkGeneric 12/2010 - 03/2006
3	alvocidib (flavopiridol)IBA 12/2010 - 01/2009
3	Therapeutic UsesIBA 02/2010 - 06/2008
3	OligodeoxyribonucleotidesIBA 02/2010 - 04/2008
3	Antisense OligodeoxyribonucleotidesIBA 11/2009 - 03/2006
3	NF-kappa B (NF-kB)IBA 08/2009 - 02/2008

Therapy/Procedure

64	Therapeutics 05/2024 - 02/2002
33	Drug Therapy (Chemotherapy) 04/2024 - 01/2003
28	Cell Transplantation 03/2024 - 01/2006
11	Transplantation 11/2023 - 07/2008
7	Homologous Transplantation 01/2022 - 11/2009
6	Stem Cell Transplantation 12/2017 - 01/2006
5	Salvage Therapy 01/2023 - 08/2005
5	Hematopoietic Stem Cell Transplantation 12/2019 - 01/2016
4	Consolidation Chemotherapy 01/2020 - 06/2005
3	Induction Chemotherapy 05/2024 - 02/2002
3	Lymphatic Irradiation 01/2022 - 04/2017